Peut entraîner des neuropathies, des maladies rénales et des problèmes de vision.
DiabèteComplicationsSanté masculine
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour le cancer de la prostate ?
Âge avancé, antécédents familiaux et obésité sont des facteurs de risque connus.
Cancer de la prostateFacteurs de risqueSanté masculine
#2
Quels facteurs de risque pour les maladies cardiaques ?
Hypertension, diabète, tabagisme et sédentarité augmentent le risque de maladies cardiaques.
Maladies cardiaquesFacteurs de risqueSanté masculine
#3
Quels facteurs de risque pour la dysfonction érectile ?
Diabète, maladies cardiovasculaires, stress et certains médicaments peuvent contribuer.
Dysfonction érectileFacteurs de risqueSanté masculine
#4
Quels sont les facteurs de risque de dépression chez les hommes ?
Antécédents familiaux, stress chronique et problèmes relationnels peuvent augmenter le risque.
DépressionFacteurs de risqueSanté mentale
#5
Quels facteurs de risque pour le diabète de type 2 ?
Obésité, sédentarité, antécédents familiaux et alimentation déséquilibrée sont des facteurs clés.
Diabète de type 2Facteurs de risqueSanté masculine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Santé masculine : Questions médicales les plus fréquentes",
"headline": "Santé masculine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Santé masculine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Santé masculine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Santé",
"url": "https://questionsmedicales.fr/mesh/D006262",
"about": {
"@type": "MedicalCondition",
"name": "Santé",
"code": {
"@type": "MedicalCode",
"code": "D006262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N01.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Santé masculine",
"alternateName": "Men's Health",
"code": {
"@type": "MedicalCode",
"code": "D054526",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Louise M Waite",
"url": "https://questionsmedicales.fr/author/Louise%20M%20Waite",
"affiliation": {
"@type": "Organization",
"name": "Centre of Education and Research on Ageing, Ageing and Alzheimer's Institute, University of Sydney and Concord Hospital, Australia."
}
},
{
"@type": "Person",
"name": "Fiona M Blyth",
"url": "https://questionsmedicales.fr/author/Fiona%20M%20Blyth",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Vasi Naganathan",
"url": "https://questionsmedicales.fr/author/Vasi%20Naganathan",
"affiliation": {
"@type": "Organization",
"name": "Centre of Education and Research on Ageing, Ageing and Alzheimer's Institute, University of Sydney and Concord Hospital, Australia."
}
},
{
"@type": "Person",
"name": "Robert G Cumming",
"url": "https://questionsmedicales.fr/author/Robert%20G%20Cumming",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Sydney, Australia."
}
},
{
"@type": "Person",
"name": "David J Handelsman",
"url": "https://questionsmedicales.fr/author/David%20J%20Handelsman",
"affiliation": {
"@type": "Organization",
"name": "ANZAC Research Institute, University of Sydney and Concord Hospital, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Impact of Needle and Syringe Exchange Programs on HIV-Related Risk Behaviors in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis Examining Individual- Versus Community-Level Effects.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37046029",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10461-023-04051-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37773035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003718"
}
},
{
"@type": "ScholarlyArticle",
"name": "The impact of a 24-hour syringe dispensing machine on a face-to-face needle and syringe program and targeted primary healthcare clinic.",
"datePublished": "2022-06-09",
"url": "https://questionsmedicales.fr/article/35679052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1753-6405.13267"
}
},
{
"@type": "ScholarlyArticle",
"name": "Service Utilization among Persons Who Inject Drugs Attending a Syringe Exchange Program in New York State.",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36814373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10826084.2023.2177965"
}
},
{
"@type": "ScholarlyArticle",
"name": "Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach.",
"datePublished": "2024-06-28",
"url": "https://questionsmedicales.fr/article/38943164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-024-01037-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Caractéristiques de la population",
"item": "https://questionsmedicales.fr/mesh/D011154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé",
"item": "https://questionsmedicales.fr/mesh/D006262"
},
{
"@type": "ListItem",
"position": 4,
"name": "Santé masculine",
"item": "https://questionsmedicales.fr/mesh/D054526"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Santé masculine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Santé masculine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Santé masculine",
"description": "Comment diagnostiquer l'hypertrophie bénigne de la prostate ?\nQuels tests pour évaluer la santé sexuelle masculine ?\nComment détecter le cancer testiculaire ?\nQuels signes indiquent une maladie cardiovasculaire ?\nComment évaluer le risque de diabète chez les hommes ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Santé masculine",
"description": "Quels sont les symptômes de la dysfonction érectile ?\nComment reconnaître un cancer de la prostate ?\nQuels signes indiquent une dépression chez les hommes ?\nQuels symptômes d'une maladie cardiaque chez les hommes ?\nQuels symptômes d'un déséquilibre hormonal ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Santé masculine",
"description": "Comment prévenir le cancer de la prostate ?\nQuelles mesures pour prévenir la dysfonction érectile ?\nComment réduire le risque de maladies cardiaques ?\nQuelles sont les recommandations pour la santé mentale ?\nComment prévenir le diabète de type 2 ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Santé masculine",
"description": "Quels traitements pour la dysfonction érectile ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQuelles sont les options pour le cancer testiculaire ?\nComment traiter la dépression chez les hommes ?\nQuels traitements pour les maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Santé masculine",
"description": "Quelles complications de la dysfonction érectile ?\nQuelles complications du cancer de la prostate ?\nQuels risques associés à l'hypertrophie bénigne de la prostate ?\nQuelles complications des maladies cardiovasculaires ?\nQuelles complications du diabète non contrôlé ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Santé masculine",
"description": "Quels sont les facteurs de risque pour le cancer de la prostate ?\nQuels facteurs de risque pour les maladies cardiaques ?\nQuels facteurs de risque pour la dysfonction érectile ?\nQuels sont les facteurs de risque de dépression chez les hommes ?\nQuels facteurs de risque pour le diabète de type 2 ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypertrophie bénigne de la prostate ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen physique, un dosage du PSA et une échographie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la santé sexuelle masculine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux, un examen physique et des questionnaires sur la fonction érectile sont courants."
}
},
{
"@type": "Question",
"name": "Comment détecter le cancer testiculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'auto-examen, l'échographie et les marqueurs tumoraux sont essentiels pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie cardiovasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, essoufflement et fatigue peuvent signaler une maladie cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de diabète chez les hommes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de glycémie à jeun et une évaluation des facteurs de risque sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la dysfonction érectile ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficulté à obtenir ou maintenir une érection, souvent accompagnée de stress ou d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un cancer de la prostate ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des difficultés urinaires, des douleurs pelviennes et du sang dans les urines."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dépression chez les hommes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, irritabilité, perte d'intérêt et changements d'appétit sont des signes courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie cardiaque chez les hommes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, essoufflement, palpitations et fatigue excessive peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un déséquilibre hormonal ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Changements d'humeur, fatigue, prise de poids et diminution de la libido peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer de la prostate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et des examens médicaux réguliers sont conseillés."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir la dysfonction érectile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter le tabac et gérer le stress sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de maladies cardiaques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et contrôler la pression artérielle aide."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la santé mentale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer la pleine conscience, maintenir des relations sociales et consulter un professionnel si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le diabète de type 2 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et le contrôle du poids sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dysfonction érectile ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments, des dispositifs sous vide et des thérapies psychologiques."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hypertrophie bénigne de la prostate ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies minimales invasives et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour le cancer testiculaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chirurgie, chimiothérapie et radiothérapie sont les principales options de traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter la dépression chez les hommes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie, les médicaments antidépresseurs et le soutien social."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les maladies cardiovasculaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des médicaments, des changements de mode de vie et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dysfonction érectile ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des problèmes relationnels, une dépression et une diminution de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications du cancer de la prostate ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut inclure des problèmes urinaires, des douleurs chroniques et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels risques associés à l'hypertrophie bénigne de la prostate ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer des infections urinaires, des calculs vésicaux et des complications chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles complications des maladies cardiovasculaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peuvent inclure des crises cardiaques, des AVC et des insuffisances cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications du diabète non contrôlé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des neuropathies, des maladies rénales et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer de la prostate ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, antécédents familiaux et obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les maladies cardiaques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Hypertension, diabète, tabagisme et sédentarité augmentent le risque de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dysfonction érectile ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diabète, maladies cardiovasculaires, stress et certains médicaments peuvent contribuer."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de dépression chez les hommes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antécédents familiaux, stress chronique et problèmes relationnels peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le diabète de type 2 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Obésité, sédentarité, antécédents familiaux et alimentation déséquilibrée sont des facteurs clés."
}
}
]
}
]
}
Yunus Centre for Social Business and Health, Glasgow Caledonian University, M201 George Moore Building, Cowcaddens Road, Glasgow, G4 0BA, UK. Artur.steiner@gcu.ac.uk.
Centre for Education and Research on Ageing, Concord Clinical School, Sydney Local Health District, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
We conducted a systematic review and meta-analysis of the impact of needle and syringe exchange programs (NSP) on both individual- and community-level needle-sharing behaviors and other HIV-related ou...
Needle and syringe programs (NSPs) are effective at preventing HIV and hepatitis C virus (HCV) among people who inject drugs (PWID), yet global coverage is low, partly because governments lack data on...
We conducted a systematic review to extract data on the cost per syringe distributed and its cost drivers. We estimated the impact of country-level and program-level variables on the cost per syringe ...
We identified 55 estimates of the unit cost per syringe distributed from 14 countries. Unit costs were extrapolated for 137 countries, ranging from $0.08 to $20.77 (2020 USD) per syringe distributed. ...
Our review identified cost estimates from high-income, upper-middle-income, and lower-middle-income countries. Regression models may be useful for estimating NSP costs in countries without data to inf...
Automatic syringe dispensing machines (ADM) have become an important adjunct to Australia's needle and syringe programs (NSP). However, concerns that they reduce face-to-face contact with health staff...
We reviewed data from an inner-city harm reduction program during the study period of April 2020 to March 2021 compared to the previous year. Multivariable linear regression models were used to estima...
ADM-dispensed equipment increased significantly by 41.1%, while face-to-face NSP occasions decreased by 16.2%. Occasions provided by the targeted primary healthcare clinic increased by 59.7% per month...
We have shown that 24-hour ADM access did not adversely affect the number of people using targeted primary healthcare when provided within close proximity. Implication for public health: These finding...
Epidemiologic studies commonly recommend the integration of harm reduction programs with health and social services to improve the well-being of persons who inject drugs (PWIDs). This study identified...
We applied Multiple Correspondence Analysis and Hierarchical Clustering on Principal Components to classify 475 PWIDs into clusters using anonymized, SEP records data from New York. Multinomial logist...
Only 22% of participants utilized at least one service. We identified three clusters of service utilization defined by 1) Nonuse; 2) Support, Primary Care, & Maintenance service use; and 3) HIV/STD, S...
Overall, PWID clients had a low prevalence of in-house service use particularly those who live alone. However, higher service utilization was observed among more vulnerable populations (i.e., non-Whit...
Needle and syringe programs (NSP) are effective harm-reduction strategies against HIV and hepatitis C. Although skin, soft tissue, and vascular infections (SSTVI) are the most common morbidities in pe...
We performed a model-based, economic evaluation comparing a scenario with NSP to a scenario without NSP. We developed a microsimulation model to generate two cohorts of 100,000 individuals correspondi...
The incremental cost-effectiveness ratio associated with NSP was $70,278 per QALY, with incremental cost and QALY gains corresponding to $1207 and 0.017 QALY, respectively. Under the scenario with NSP...
Both the individuals and the healthcare system benefit from NSP through lower risk of SSTVI mortality and prevention of recurrent outpatient and emergency department visits to treat SSTVI. The microsi...
The World Health Organization has set a goal to reach world elimination of hepatitis C virus (HCV) by 2030. Needle and syringe programs (NSP) for people who inject drugs (PWID) are crucial to achieve ...
Data from 450 PWID registered at the Uppsala NSP between 2016-11-01 and 2021-12-31 were collected from the national quality registry InfCare NSP. Data from the 101 PWID treated for HCV at the Uppsala ...
The mean age was 35 years. 75% were males (336/450), and 25% were females (114/450). The overall HCV prevalence was 48% (215/450) with a declining trend over time. Factors associated with a higher ris...
HCV prevalence, treatment uptake and treatment outcome have improved since the opening of the Uppsala NSP. However, further measures are needed to reach the HCV elimination goal. Outreach HCV treatmen...
Although the Netherlands, Canada and Australia were early adopters of harm reduction for people who inject drugs (PWID), their respective HIV and hepatitis C (HCV) epidemics differ. We measured the po...
For each cohort, we emulated the design and statistical analysis of a target trial using observational data....
We included PWID at risk of HIV or HCV infection from the Amsterdam Cohort Studies (1985-2013), Vancouver Injection Drug Users Study (1997-2009) and Melbourne Injecting Drug User Cohort Study (SuperMI...
Separately for each infection and cohort (only HCV in SuperMIX), marginal structural models were used to compare the effect of comprehensive (on OAT and 100% NSP coverage or on OAT only if no recent i...
We observed 94 HIV seroconversions and 81 HCV seroconversions among 2023 and 430 participants, respectively. Comprehensive NSP/OAT led to a 41% lower risk of HIV acquisition (pooled HR = 0.59, 95% CI ...
In the Netherlands, Canada and Australia, comprehensive needle and syringe program and opioid agonist therapy participation appears to substantially reduce HIV and hepatitis C acquisition compared wit...
Kentucky is one of ten states that require syringe services program (SSP) approval from local officials to operate legally. Public health leaders and local officials participated in semi-structured in...
Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants. SSPs can ...
Using the Consolidated Framework for Implementation Research (CFIR), we conducted 12 key informant interviews with SSP staff to describe the overall landscape of data systems at SSPs, understand facil...
Four main themes emerged from our analysis: SSP M&E systems are primarily designed to be responsive to perceived SSP client needs and preferences; SSP staffing capacity influences the likelihood of mo...
Our findings highlight that SSPs are not resistant to data collection and M&E, but face substantial barriers to implementation, including lack of funding and disjointed data reporting requirements. Th...
Australian harm reduction services are provided via a mix of modalities, including fixed-site needle and syringe programmes (NSP) and syringe-dispensing machines (SDMs). SDMs are cost-effective and pr...
Our data span September 2017-December 2020. We analysed daily counts of SDM use and monthly counts of NSP use, according to unique presentations to both. Auto-regressive integrated moving average (ARI...
Across the study period, we estimated 85,851 SDM presentations and 29,051 NSP presentations. Usage across both the SDMs and the NSP declined during the COVID-19 lockdowns, but only the decline in SDM ...
The slight, but significant decline in SDM use suggests barriers to access, though this may have been mitigated by SDM users acquiring needles/syringes from other sources. The decline, however, may be...
